Viroelixir Exhibits Cell-Line-Specific Anticancer Activity and Enhances Chemosensitivity in Oral Squamous Cell Carcinoma: Associated Changes in Apoptosis, Redox Homeostasis, and Oncogenic Signaling
Oral squamous cell carcinoma (OSCC) remains a major global health burden despite advances in surgery, radiotherapy, and chemotherapy. The development of novel therapeutic agents with improved efficacy and reduced toxicity is therefore urgently needed. This study investigated the anticancer potential of Viroelixir, a na...